Compass Group PLC Sponsored ADR (CMPGY)
Is Compass Stock a Buy After Barrier Capital Initiated a Position Worth Over $10 Million?
Barrier Capital bought 952,074 shares of Compass; estimated trade value of $10.06 million based on quarterly average pricing. Quarter-end position value increased by $10.06 million, reflecting the new share acquisition.
CMPGY vs. BROS: Which Stock Is the Better Value Option?
Investors with an interest in Retail - Restaurants stocks have likely encountered both Compass Group PLC (CMPGY) and Dutch Bros (BROS). But which of these two stocks offers value investors a better bang for their buck right now?
Compass Group falls as guidance left unchanged
Compass Group PLC shares fell 7.7% to 2,050p on Thursday despite posting a trading update for what it called a strong start to the year and reaffirming its full-year guidance. The FTSE 100 catering group reporting 7.3% organic revenue growth for the first quarter, which was down from the 8.7% growth seen in the past full year.
Will Compass be an AI loser from lower office demand? UBS thinks not
The recent pullback in Compass Group PLC (LSE:CPG) shares is unjustified, according to UBS, which argues that the market's concerns around the potential impact of AI on employment and demand for workplace catering are overcooked. In a note to clients, the Swiss bank noted that some investors view the FTSE 100 group as an "AI loser", hit by second-order effects as job displacement in the wider economy leads to top-line pressure.
Compass Therapeutics: Exciting Clinical Updates Inbound For 2026
Compass Therapeutics remains a 'Buy,' but valuation above $1B stretches risk/reward as it awaits pivotal clinical catalysts. Tovecimig's early data in biliary tract and refractory colorectal cancers show promise, with key COMPANION-002 updates expected late Q1 2026. CMPX's cash runway extends into 2028, supporting continued clinical progress and mitigating near-term financing risk.
Compass (COMP) Upgraded to Buy: Here's Why
Compass (COMP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Compass Pathways: Exciting Prospects For This Psychedelic Pioneer With Significant Risks
Compass Pathways plc experienced an >80% rally since my last 'Hold' rating. CMPS has benefited from positive phase 3 trial results and positive political developments since my last article. Recent approval of JNJ's Spravato as a standalone product in treatment of TRD offers significant piggybacking opportunity for Compass.
Compass (COMP) Surges 9.3%: Is This an Indication of Further Gains?
Compass (COMP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Compass Diversified Restated Q1: Too Risky To Gamble (Rating Downgrade)
Compass Diversified faces severe financial distress following the Lugano fraud, with breached debt covenants and a "Going Concern" warning. CODI's restated Q1 results reveal a dramatic reduction in revenues and profitability, with EBITDA guidance slashed from $570m-$610m to $330m-$360m. Lugano's Chapter 11 filing and deconsolidation will further reduce inventories by 40% and Lugano revenues by 85%, compounding CODI's challenges.
Is Compass (COMP) Stock Outpacing Its Computer and Technology Peers This Year?
Here is how Compass, Inc. (COMP) and Amtech Systems (ASYS) have performed compared to their sector so far this year.
2026 will be next chapter of housing market story, says Compass Mike Simonsen
Mike Simonsen, Compass Chief Economist, joins 'Fast Money' to talk whats ahead for the housing market in 2026.
Butterfly Network: Midjourney Deal Priced In, Compass AI Remains The Swing Factor
Butterfly Network, Inc. (BFLY) is rated 'Hold' as recent upside from the Midjourney licensing deal appears fully priced in. BFLY's high valuation is at odds with ongoing unprofitability, significant inventory write-downs, and slower revenue growth versus peers. Core upside hinges on successful adoption of Compass AI and POCUS stack to drive recurring, higher-margin revenue.
